Cite
Smits BM, Kleine Budde I, de Vries E, et al. Immunoglobulin Replacement Therapy Versus Antibiotic Prophylaxis as Treatment for Incomplete Primary Antibody Deficiency. J Clin Immunol. 2020;41(2):382-392doi: 10.1007/s10875-020-00841-3.
Smits, B. M., Kleine Budde, I., de Vries, E., Ten Berge, I. J. M., Bredius, R. G. M., van Deuren, M., van Dissel, J. T., Ellerbroek, P. M., van der Flier, M., van Hagen, P. M., Nieuwhof, C., Rutgers, B., Sanders, L. E. A. M., Simon, A., Kuijpers, T. W., & van Montfrans, J. M. (2021). Immunoglobulin Replacement Therapy Versus Antibiotic Prophylaxis as Treatment for Incomplete Primary Antibody Deficiency. Journal of clinical immunology, 41(2), 382-392. https://doi.org/10.1007/s10875-020-00841-3
Smits, Bas M, et al. "Immunoglobulin Replacement Therapy Versus Antibiotic Prophylaxis as Treatment for Incomplete Primary Antibody Deficiency." Journal of clinical immunology vol. 41,2 (2021): 382-392. doi: https://doi.org/10.1007/s10875-020-00841-3
Smits BM, Kleine Budde I, de Vries E, Ten Berge IJM, Bredius RGM, van Deuren M, van Dissel JT, Ellerbroek PM, van der Flier M, van Hagen PM, Nieuwhof C, Rutgers B, Sanders LEAM, Simon A, Kuijpers TW, van Montfrans JM. Immunoglobulin Replacement Therapy Versus Antibiotic Prophylaxis as Treatment for Incomplete Primary Antibody Deficiency. J Clin Immunol. 2021 Feb;41(2):382-392. doi: 10.1007/s10875-020-00841-3. Epub 2020 Nov 18. PMID: 33206257; PMCID: PMC7858555.
Copy
Download .nbib